That is similar to what was observed for the polymorphisms PAR1 (rs11267092) and TP53 (rs17878362), where their Del/Del genotypes also demonstrated an association with the lowest risk for the development of NSCLC (Table 4). This evidence concerns the gene TP53 and non-small cell lung carcinoma.